VentureMed is beginning a study to assess whether its Flex dynamic scoring catheter can reduce dissections, as well as the need for bailout stents in peripheral arteries when treating patients with femoropopliteal de novo or no-stent restenosis. The study will include 15 patients.
Study begins for VentureMed's dynamic scoring catheter
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.